ProfileGDS4718 / 221732_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 98% 98% 92% 99% 99% 98% 97% 99% 99% 99% 98% 98% 98% 97% 98% 98% 99% 97% 98% 98% 99% 99% 99% 99% 98% 98% 99% 97% 98% 98% 97% 98% 98% 98% 99% 98% 98% 99% 99% 88% 98% 98% 98% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.833398
GSM549102patient 115, normal, homogenized [OPG study]11.820598
GSM549104patient 119, normal, homogenized [OPG study]9.6922692
GSM549108patient 138, normal, homogenized [OPG study]12.149499
GSM549119patient 077, normal, homogenized [OPG study]11.947199
GSM549133patient 032, cancer, homogenized [OPG study]11.210498
GSM549139patient 042, cancer, homogenized [OPG study]10.974497
GSM549099patient 107, normal, homogenized [OPG study]12.018199
GSM549109patient 139, normal, homogenized [OPG study]12.060199
GSM549110patient 046, normal, homogenized [OPG study]12.016299
GSM549114patient 063, normal, homogenized [OPG study]12.066998
GSM549122patient 082, normal, homogenized [OPG study]11.684198
GSM549134patient 033, cancer, homogenized [OPG study]11.470498
GSM549136patient 036, cancer, homogenized [OPG study]11.004997
GSM549140patient 044, cancer, homogenized [OPG study]11.135198
GSM549111patient 047, normal, homogenized [OPG study]11.936498
GSM549113patient 057, normal, homogenized [OPG study]12.180399
GSM549132patient 031, cancer, homogenized [OPG study]10.880697
GSM549137patient 038, cancer, homogenized [OPG study]11.679998
GSM549142patient 047, cancer, homogenized [OPG study]10.709598
GSM549100patient 110, normal, homogenized [OPG study]12.135999
GSM549107patient 135, normal, homogenized [OPG study]12.329699
GSM549115patient 068, normal, homogenized [OPG study]12.098199
GSM549116patient 072, normal, homogenized [OPG study]11.984899
GSM549120patient 078, normal, homogenized [OPG study]11.795198
GSM549131patient 030, cancer, homogenized [OPG study]11.434998
GSM549118patient 074, normal, homogenized [OPG study]12.072299
GSM549129patient 027, cancer, homogenized [OPG study]10.632797
GSM549123patient 088, normal, homogenized [OPG study]11.850198
GSM549124patient 006, cancer, homogenized [OPG study]11.391698
GSM549126patient 015, cancer, homogenized [OPG study]10.979897
GSM549128patient 025, cancer, homogenized [OPG study]11.320398
GSM549103patient 117, normal, homogenized [OPG study]11.766498
GSM549117patient 073, normal, homogenized [OPG study]11.949498
GSM549138patient 041, cancer, homogenized [OPG study]11.891299
GSM549141patient 045, cancer, homogenized [OPG study]11.576298
GSM549130patient 028, cancer, homogenized [OPG study]11.499298
GSM549101patient 111, normal, homogenized [OPG study]11.960899
GSM549105patient 128, normal, homogenized [OPG study]12.105999
GSM549106patient 134, normal, homogenized [OPG study]9.0254188
GSM549112patient 048, normal, homogenized [OPG study]11.605198
GSM549125patient 011, cancer, homogenized [OPG study]11.294198
GSM549127patient 024, cancer, homogenized [OPG study]11.053698
GSM549135patient 035, cancer, homogenized [OPG study]10.751797